by the hyperglycemic clamp technique (6.9 mmol/l). Magnetic resonance imaging was used to quantify visceral and subcutaneous abdominal fat depots. In obese girls, an impairment in glucose disposal was present with both insulin doses; at the higher dose, rates of glucose uptake were reduced by 30% in nonobese girls (240 -I-30 vs. 340 t 19 mg*m-2.min-1, P < 0.05) and by an additional 29% (170 t 17 mg*m-2*minl, P < 0.05) in obese girls. Insulin infusion failed to stimulate glucose oxidation and to suppress lipid oxidation only in obese girls. Suppression of free fatty acid levels, but not hepatic glucose production, was decreased in obese girls compared with controls. Fasting and glucosestimulated insulin responses were greater in obese than in nonobese adolescents, who, in turn, had greater responses than lean women. In obese girls, visceral fat, but neither waist-to-hip circumference ratio nor subcutaneous fat, was highly correlated with basal insulin secretion (r = 0.89, P < O.OOl), stimulated insulin secretion (r = 0.61, P < 0.05), and insulin resistance (r = -0.87, P < 0.02). Increased visceral fat, hyperinsulinemia, and insulin resistance (involving glucose and lipid metabolism) are closely linked abnormalities that are expressed early in the natural history of obesity.
establish whether alterations in insulin action and secretion and their relationship to body fat distribution occur early in the course of developing obesity, we studied 14 obese adolescent girls [13.2 _ .
+ 0 7 yr, body mass index (BMI) 32 t 1.41, 16 nonobese adolescent girls (12.5 2 0.6 yr, BMI 21.0 * 0.8), and 14 nonobese young women (24.0 t 0.6 yr, BMI 21.0 t 0.9). Insulin action was assessed by a sequential two-step (8 and 40 mU l mm2 l min-l) euglycemic insulin clamp in combination with [ lJ3C]glucose and indirect calorimetry. Insulin secretion was determined by the hyperglycemic clamp technique (6.9 mmol/l). Magnetic resonance imaging was used to quantify visceral and subcutaneous abdominal fat depots. In obese girls, an impairment in glucose disposal was present with both insulin doses; at the higher dose, rates of glucose uptake were reduced by 30% in nonobese girls (240 -I-30 vs. 340 t 19 mg*m-2.min-1, P < 0.05) and by an additional 29% (170 t 17 mg*m-2*minl, P < 0.05) in obese girls. Insulin infusion failed to stimulate glucose oxidation and to suppress lipid oxidation only in obese girls. Suppression of free fatty acid levels, but not hepatic glucose production, was decreased in obese girls compared with controls. Fasting and glucosestimulated insulin responses were greater in obese than in nonobese adolescents, who, in turn, had greater responses than lean women. In obese girls, visceral fat, but neither waist-to-hip circumference ratio nor subcutaneous fat, was highly correlated with basal insulin secretion (r = 0.89, P < O.OOl), stimulated insulin secretion (r = 0.61, P < 0.05), and insulin resistance (r = -0.87, P < 0.02). Increased visceral fat, hyperinsulinemia, and insulin resistance (involving glucose and lipid metabolism) are closely linked abnormalities that are expressed early in the natural history of obesity. Adolescents with central adiposity should be targeted for weight reduction and health surveillance to reduce morbidity of.adult obesity.
visceral fat mass; glucose uptake; insulin secretion; free fatty acid; insulin resistance THE ADVERSE METABOLIC and clinical consequences of obesity in adults have been the focus of intense investigation over the past several years. Recently, it has become increasingly apparent that the excessive fat deposition within the abdominal cavity has profound effects on tissue sensitivity to insulin and pancreatic P-cell function in obese adults (21) . Insulin resistance and compensatory hyperinsulinemia have been linked with increased risks for hypertension, dyslipidemia, hyperuricemia, and ultimately development of type II (non-insulin-dependent) diabetes (28). This clustering of abnormalities, which has been referred to as syndrome X (28), is also associated with an increase in intraabdominal (or visceral) fat (2). Bjijrntorp (2), Kissebah and Peiris (21), and Peiris et al. (26) suggested that enlarged intra-abdominal adipocytes, which have a much higher lipolytic rate than gluteal fat cells (4), may release increased quantities of free fatty acids (FFA) into the portal circulation, exposing the liver and peripheral tissues to elevated FFA concentrations, which, in turn, could impair glucose metabolism (27) . Increased delivery of FFA in the portal system may also reduce the hepatic clearance of insulin (32), producing peripheral hyperinsulinemia, which could lead to secondary insulin resistance by downregulating insulin receptors. Obesity in adults is usually long lasting. Hence, the association of generalized insulin resistance, compensatory hyperinsulinemia, and increased visceral fat mass in these obese adults may simply reflect adaptations to long-term obesity rather than a causal relationship. The study of obesity in children and adolescents, on the other hand, offers the opportunity to elucidate metabolic defects occurring early in the natural history of obesity, because its presence is relatively short term. More importantly, the model of childhood obesity is free from long-term effects of life-style conditions, such as smoking, chronic alcohol consumption, and uncontrollable stress, which are known to strongly influence fat distribution and its metabolic correlates (2). Furthermore, by studying obesity in children, therapeutic strategies in combating obesity may be implemented earlier in the course of the disease.
In contrast to the active study of obesity in adults, little is known about the early metabolic defects and the antecedents of obesity-related complications in overweight adolescents. Few studies have employed sophisticated glucose-clamping techniques to examine obesityinduced alterations in insulin action and insulin secretion in adolescents (7, 22) . Moreover, safety issues (ionizing radiation) have limited the use of computerized tomography for measurement of intra-abdominal fat in young subjects. In the present study, we utilized the euglycemichyperinsulinemic and hyperglycemic clamp techniques together with magnetic resonance imaging (MRI) to examine changes in glucose and lipid metabolism in vivo and their relationship to fat distribution in obese adolescent girls. We sought to determine whether the insulin resistance, hyperinsulinemia, and increased intraabdominal fat that typify central obesity in adults are expressed early in the course of developing obesity. 1971-19741 (19) . Tanner stages of pubic hair and breast development ranged from stage II to IV. Specifically, four obese girls were in Tanner stage II, three girls were in Tanner stage III, and seven were in Tanner stage IV. Two groups of subjects were used as controls. The first group consisted of 16 adolescent girls (15 Caucasian and 1 African-American).
All control subjects had a BMI within the 50th percentile specific for age and sex (NHANES I) (19) d an were matched closely for age and Tanner stage to the obese group. Six nonobese girls were in Tanner stage II, five were in Tanner stage III, and five were in Tanner stage IV. The second control group consisted of 14 nonobese Caucasian young adult females (Table l) , with a mean BMI of 24 t 0.56. There was no decrease in body weight in any of the obese and control subjects for 2 3 mo before the study. None of the obese girls had a first degree relative with diabetes mellitus, and all obese girls had at least one obese parent (BMI > 30). Control subjects had a negative family history of diabetes, and only two control girls had an obese parent Weight (to the nearest 0.1 kg) and height (to the nearest 0.5 cm) were measured while the subjects were fasting and wearing only their undergarments. Waist-to-hip circumference ratios (WHR) were determined (to nearest 0.5 cm) with a plastic tape measure while the subject was standing: the circumference of the waist (widest diameter between xiphoid process of sternum and iliac crest) and circumference of the hip (widest diameter over greater trochanters).
A WHR > 0.76 indicated a predominance of central (abdominal) adiposity, whereas a WHR < 0.76 indicated peripheral (gluteal) adiposity.
MRI was employed to directly assess intra-abdominal fat deposition (31). After an overnight fast, the MRI scans were performed utilizing a 1.5-T scanner (Sigma, General Electric, Milwaukee, WI). Two series of localizer scans were obtained with the following Tl weights spin-echo technique: repetitive time (TR) 500, echo time (TE) 20,5-mm slice thickness with a 5-mm skip, 256 x 128 matrix, and two signal averages. The sagittal scan was used to establish the reference point for the midabdomen (L 4-5 disk space), and the coronal scans were used to establish the reference point for the hips (greater trochanters).
Axial cluster scans with TR 400, TE 20, lo-mm slice thickness with 5-mm skip, 256 x 128 matrix, and two NEX were then obtained through the abdomen and hips. The volume of fat within a slice was calculated using an interactive computer program (Command Line Image Processing System, General Electric). Determination of fractional fat was performed by using interactive level detection with a threshold to separate fat from nonfat by pixel signal intensity. Images were then created with only the pixel representing fat tissue. Total and visceral abdominal fat were measured by outlining the total and intra-abdominal area, respectively, and determining the number of bright pixels in the area. Subcutaneous fat was taken as the total abdominal fat minus the visceral fat. Pelvic fat was determined by measuring the total number of pixels representing fat in the appropriate slice and subtracting the light pixels representing bone marrow in that area. The MRI was performed in 13 obese and 9 nonobese girls and 13 lean adult women.
Metabolic Studies
On the day of the study, subjects were admitted at 0800 to the Yale General Clinical Research Center (child or adult unit). All studies were performed in the postabsorptive state after an overnight fast of lo-12 h, with the subject lying supine in a quiet room. Two intravenous catheters were inserted before the clamp studies: one in an antecubital vein for administration of test substances and the other in a vein of the hand or distal forearm of the contralateral arm for blood sampling. The hand chosen for blood sampling was placed in a heated box El20 FAT DISTRIBUTION AND GLUCOSE METABOLISM IN ADOLESCENCE OBESITY ( = 65°C) to facilitate blood sampling and to arterialize blood. Videotaped movies entertained the children and kept them relaxed before and during the infusion studies. The following studies were performed: 1) a sequential two-step euglycemic insulin clamp in combination with the infusion of [l-13C]glucase and indirect calorimetry and 2) a +6.9 mmol/l (+ 125 mg/dl) hyperglycemic clamp. The two studies were performed in random order at 2-mo intervals.
Euglycemic insuhn clamp. Total body insulin sensitivity was measured by a two-step euglycemic insulin clamp, during which insulin was administered as a prime-continuous infusion at 8 and 40 mU l min-l l m body surface area-? Each step lasted for 120 min. The low (8 mu) and high (40 mu) insulin infusion rates were chosen, because they produce plasma insulin levels close to the half-maximal suppression of plasma FFA and hepatic glucose production (HGP) and half-maximal stimulation of total glucose disposal, respectively (10, 17 Urine was collected during the baseline and insulin clamp periods and analyzed for urinary nitrogen excretion, which was used to calculate protein oxidation. Seven obese and 9 nonobese girls and 12 lean young females participated in this study.
Hyperglycemic clamp. The glucose clamp technique was used to assess the secretory response of pancreatic P-cells to a standard increase in plasma glucose in obese and nonobese adolescents and healthy lean adults. After the collection of three baseline samples, glucose was acutely raised by 6.9 mmol/l (125 mg/dl) with a priming infusion of 20% glucose. Subsequently, plasma glucose (measured at 5min intervals) was held constant at this hyperglycemic level for 120 min by appropriate adjustment of a variable-rate 20% glucose infusion. Blood samples were also obtained at 2,4,6,8, and 10 min and every 10 min thereafter for 120 min, for measurements of plasma insulin and C-peptide concentrations.
Urine was collected at the beginning and end of the procedure for determination of glucose content. Thirteen obese and 14 nonobese girls and 6 lean women participated in this study.
Determinations and Calculations
Plasma and urine glucose levels were measured by the glucose oxidase method with a glucose analyzer (Beckman Instruments, Brea, CA). Plasma insulin, C-peptide, and glucagon were measured by a double-antibody radioimmunoassay. Plasma FFA was assayed by a calorimetric method (25) and urinary nitrogen by the Kjeldahl procedure (20). Total hemoglobin Ai was measured chromatographically with a microcolumn (Isolab, Akron, OH). Plasma dehydroepiandrosterone sulfate was measured by radioimmunoassay.
The 13C enrichment of plasma glucose was determined by gas chromatography-mass spectrometry of the pentaacetate derivatives of glucose after deproteinization and deionization, as previously described (34). Gas chromatography-mass spectrometry analysis was performed with a Hewlett-Packard 5890 gas chromato- raised to the same hyperglycemic plateau of -7 mM Basal HGP was not significantly different in nonobese above the basal level during the study in all three groups adults (90 t 3 mg=mm2 emin-l), nonobese adolescents (Fig. 3) . The increments in plasma glucose also produced (107 t 4mg*mB2 ami&), and obese adolescents (100 t 9 the same biphasic pattern of insulin responses in all mg*rnS2* min-l). During low and high insulin infusions, subjects. However, the magnitude of the responses glucose production was markedly suppressed to a simivaried greatly among the three groups. The first (336 t lar degree in all groups (data not shown).
54 pmol)-and late-phase (486 t 60 pmol) insulin reThe low-dose insulin infusion significantly stimulated sponges in the nonobese ad&scents were significantly glucose disposal rates only in the adult group (from 90 t 3 to 142 t 12 mg*mB2*minB1, P < 0.05; Fig. 1 ). Moregreater than corresponding values in the nonobese adults (174 + 24 and 234 + 36 pm01 respectively P < --over, during the high-dose insulin infusion, glucose disposal rates were markedly different among the three 0.001). However, the most striking increase in plasma insulin levels was in the obese adolescents (lst-phase groups:
compared with nonobese adults, glucose dis-insulin 510 posal rates were reduced by 30% in nonobese adoles-+ 42 pmol, late-phase insulin 930 t 120 cents (340 t 30 vs. 240 t 19 mg.mS2*minlY P < 0.05) pmol), who had insulin levels approximately twofold and by an additional 29% (170 t 17 mg*m-2=min-1, higher than the nonobese adolescent girls (P < 0.001) P < 0.05) in the obese adolescents compared with the and three-to fourfold higher than the nonobese adults nonobese adolescents. The defect in insulin-stimulated (P < 0.0001). Similarly, the first-phase C-peptide reglucose metabolism during the high-dose insulin infusponge (1 930 t 120 pmol) and the late-phase response sion in nonobese adolescents vs. nonobese adults was (3,570 t 690 pmol) of the obese adolescents were also accounted for by a reduction in nonoxidative glucose markedly greater than the responses achieved in the disposal (storage), because rates of glucose oxidation nonobese adolescents [1,150 t 160 pmol (P < 0.01) in were similar in both groups before and during the lowlst phase 2 170 + 330 pmol (P < 0.01) in late phase] and adults i750 -and high-dose insulin infusions (Fig. 1) . In contrast, the t 60 pmol (P < 0.01) in 1st phase, rates of oxidative and nonoxidative glucose disposal in 1,220 t 270 pm01 (p < o.ol> in late phase].
obese adolescents were reduced in comparison to nonThe mean rate of glucose metabolism, M, during the obese adults and adolescents (P < 0.05).
last hour of the hyperglycemic clamp was similar in all
Changes in plasma levels of FFA and lipid oxidation three groups (320 t 92, 320 t 36, and 307 t 26 mg= m-2. min-1 in nonobese adults and nonobese and obese rates before and during the insulin infusion are shown in Fig. 2 . Basal plasma FFA levels and lipid oxidation adolescents, respectively), despite much higher plasma insulin levels in the obese and nonobese adolescents. rates were similar in the three groups. On the other C hand, the ability of insulin to lower FFA levels during onsequently, M/I, an index of insulin sensitivity, in the obese adolescents (1.9 5 0.2) was -50% of that in the the low-and high-dose infusions was SiiPifiCantlY decreased in nonobese adolescents VS. adults and further nonobese adolescents (3 7 + 0.5) and only 25% of that in the nonobese adults (7.3 reduced in obese adolescents (Fig. 2) . A similar pattern k-1.7, P < 0.01).
of response between the groups was observed regarding insulin-induced suppression of lipid oxidation, except no A n th ropometric Measurements, Fat Distribution, change in lipid oxidation rates from baseline values was and Metabolism observed in the obese adolescents, even during the The anthropometric and fat distribution data are high-dose infusion (Fig. 2) . displayed in 0 in obese girls than in nonobese girls and adult women. In the obese adolescents, visceral and subcu taneous abdomi .nal fat masses were two-to threefold greater than in the nonobese adolescents (P < 0.02) and adults (P < 0.01). The femoral adipose tissue mass was also increased in the obese girls compared with both control groups. The amount of visceral abdominal fat was greater in the nonobese girls than in the lean women, whereas the abdominal subcutaneous and femoral fat were not significantly different.
The relationships between indirect indexes of adiposity and abdominal fat distribution and insulin secretion and sensitivity in the obese adolescents are reported in Table 3 . Among the indirect indexes of adiposity, only BMI was significantly correlated with insulin sensitivity. As for the two abdominal fat depots measured by MRI, a striking relation was found between the visceral fat volume and measurements of insulin secretion and sensitivity. Specifically, visceral fat correlated with basal (r = 0.89, P < 0.001) and stimulated insulin responses (r = 0.61, P < 0.05) and inversely correlated with the M/I index of insulin sensitivity (r = -0.63, P < 0.05) and insulin-stimulated glucose metabolism measured during the euglycemic clamp study (r = -0.87, P < 0.02; Table 3 ). Unlike the strong relationship between visceral fat mass and insulin secretion and sensitivity, no significant correlation was found in the obese group between subcutaneous fat, pelvic fat, or WHR (Table 3) and these metabolic measurements.
Multiple regression analyses were performed in an attempt to better quantify the independent contribution On the basis of the amount of visceral adipose tissue, the obese adolescent girls were divided into two subgroups: one with a lower amount of visceral fat ( < 150 cm3; 6 obese girls, mean visceral fat 117 t 8 cm3) and the other with a higher amount of visceral fat (> 150 cm3; 7 obese girls, mean visceral fat 197 t 20 cm3; P < 0.02)). The subcutaneous abdominal fat mass was not statistically different between the two groups (916 t 102 vs 1 05 1 + 121 cm3, low and high levels of visceral fat -mass, respectively). Insulin responses between the two subgroups of equally obese girls with different levels of visceral fat are shown in Fig. 4 . Obese girls with a high visceral fat mass showed markedly higher insulin responses to hyperglycemia than obese girls with a lower visceral fat mass, and there were similar differences in C-peptide responses as well (data not shown).
In contrast to the observations in the group of obese adolescents, no associations were observed between the abdominal visceral fat mass or the femoral adipose tissue and indexes of glucose metabolism in the groups of nonobese adolescents and adults. However, in the nonobese adolescent girls, the abdominal subcutaneous fat mass was correlated significantly with insulinstimulated glucose metabolism (r = -0.6, P < 0.05) during the euglycemic clamp. 
DISCUSSION
The present study was undertaken to examine the metabolic consequences of obesity in adolescent girls and to explore the relationships between obesity-induc-ed metabolic defects and regional fat distribution. Our study indicates that obese adolescent girls have the following characteristics: 1) insulin resistance with major defects in oxidative and nonoxidative glucose metabolism, 2) hyperinsulinemia in the fasting state and in response to intravenous glucose, and 3) impaired suppression of total body lipid oxidation and plasma FFA concentrations in response to insulin. Most importantly, this study has demonstrated that, early in the natural history of obesity, increased visceral fat mass is strongly related to insulin secretion and sensitivity. The degree of insulin resistance in the obese girls was even greater than that seen in the nonobese adolescents, in whom stimulation of whole body glucose uptake was decreased vis-a-vis the nonobese adults. Coinfusion of [ 1J3C]glucase during the clamp study also provided a means of assessing the effects of insulin on HGP. Basal HGP was similar in the three groups, even though insulin levels were markedly higher in the obese group than in both control groups. During the low and high insulin clamp, HGP was suppressed to a similar degree in all three groups. Thus the major site of insulin resistance in early obesity appears to be peripheral muscle and adipose tissues. Our findings in obese adolescents differ somewhat from those of Bougneres et al. (7) small group of prepubertal children with morbid obesity. In that study, basal HGP was higher in prepubertal obese children than in obese adults, and when insulin was raised to high physiological levels (492 pmol), hepatic glucose output was only partially suppressed in the prepubertal morbidly obese children. The fact that the degree of obesity and experimental conditions in their study were different from those in our study may explain the disparate data on insulin's effect on HGP.
After the transport of glucose into the cell and its subsequent phosphorylation, two main metabolic pathways are available: 1) irreversible loss of glucose through oxidation to CO2 and water or conversion to lipids and 2) nonoxidative glucose metabolism.
To gain further insight into the alteration of intracellular glucose metabolism in obese adolescents, indirect calorimetry was employed during the euglycemic clamp study. The results demonstrate that early in the development of obesity the defect in insulin action involves pathways of oxidative and nonoxidative glucose metabolism. Similar defects have also been reported in adult obesity (5, 6, 15) . Two enzymes, glycogen synthase and pyruvate dehydrogenase (PDH) are believed to be rate limiting for glycogen synthesis (glucose storage) and glucose oxidation, respectively (3, 24). The activity of glycogen synthase has been found to be defective in skeletal muscle biopsy specimens from obese adult subjects (12). Decreased PDH activity has also been documented in adipocytes of obese subjects (24). This insulin-sensitive enzyme, which promotes the entry of three carbon compounds into the tricarboxylic acid cycle, is inhibited by acetyl-CoA, a product of intramitochondrial oxidation of FFA. Thus the persistent elevations of FFA in the obese girls (see below) may have prevented activation of PDH and, in turn, reduced stimulation of oxidative glucose metabolism.
Obese adolescent girls also showed a marked defect in insulin's ability to suppress plasma FFA concentrations as well as lipid oxidation.
This reduced antilipolytic effect of insulin was apparent during the low-and high-dose insulin infusions. Indeed, circulating FFA levels fell by only 40% compared with the 80% suppression ach ieved in the lean adult women during the low infusion of insulin. Furthermore, when insulin was increased to the higher dose, circulating FFA levels remained twofold greater than in the adult women, despite similar steady-state plasma insulin. Whereas lipid oxidation rates were readily suppressed in the adult subjects during the low and high insulin doses in conjunction with the fall in FFA levels, in the obese girls the-rates remained elevated throughout the study. Thu .s, in the earliest stages of obesity, insuli .n resistance includes the inability of insulin to suppress lipolysis and lipid oxidation, metabolic processes that are normally exquisitely sensitive to insulin.
Hyperinsulinemia is a prevalent metabolic abnormality in adult obesity (5). Increases in plasma insulin levels have also been reported in obese children, in the fasting state and in response to an oral glucose load (30). In a relatively small group of prepubertal lean Pima Indian children, Abbott and Foley (1) found higher plasma insulin levels and plasma glucose levels during an oral glucose test than in lean Caucasian children. The study suggested that in Pima Indians there may be an inherent defect in insulin secretion or tissue sensitivity to insulin that provides a mechanism for their increased risk of obesity. In the present study, the hyperglycemic clamp technique allowed us to better assess the insulin response by providing a standardized elevation in plasma glucose. Fasting plasma insulin levels were higher in the obese girls than in the nonobese girls and the nonobese adult women. As expected, first-and late-phase glucosestimulated insulin responses were significantly greater in the nonobese adolescent girls than in the nonobese adults, changes that appear to compensate for the associated insulin resistance of normal puberty (9). Moreover the greater insulin resistance in the obese than in the nonobese adolescents was overcome by a further increase in glucose-stimulated insulin responses. Changes in C-peptide concentrations provide strong evidence that the hyperinsulinemic responses to glucose in the obese adolescents (compared with the nonobese controls) did indeed reflect increased secretion of insulin rather than decreased insulin extraction by the liver.
During the hyperglycemic clamp, the amount of glucose infused (M) to maintain the plasma glucose concentration at the desired plateau was comparable in the three groups. Because HGP is completely suppressed (23) under h yperglycemic clamp conditions, the glucose infusion rate needed to maintain the hyperglycemic plateau closely approximates the rate of total body glucose disposal. It should be noted that even though the glucose disposal was similar among the three groups, this was achieved in the obese and nonobese adolescents despite their marked hyperinsulinemia.
Therefore, to estimate insulin sensitivity during the hyperglycemic clamp, the insulin sensitivity index, M/I, was calculated. The amount of glucose metabolized per unit of plasma insulin concentration (M/I) was markedly lower in the obese adolescents, reaching values only N 50% of those of the nonobese adolescents and 25% of those of the nonobese adults. These results are entirely consistent with the results of the euglycemic clamp studies. Thus, during the hyperglycemic clamp, the increased insulin responses in obese and nonobese adolescents seem to have compensated precisely for decreased insulin sensitivity, resulting in comparable rates of glucose uptake in all three groups.
To determine whether the metabolic defects observed in the obese adolescents are linked to specific fat depots, we measured visceral, subcutaneous, and femoral fat volumes by MRI. The latter was used to differentiate accurately the visceral from the subcutaneous abdominal fat, which cannot be accomplished by simple anthropometric measurements such as the WHR. In the obese adolescent girls, significant relationships were found between the amount of visceral fat and both insulin secretion and insulin sensitivity. In contrast, no correlation was found between either the amount of subcutaneous fat or the amount of femoral adipose tissue and the metabolic indexes. These results further support the association between the amount of visceral fat and glucose-stimulated insulin responses. In keeping with this conclusion, when the obese girls were divided into two groups according to amount of visceral fat, the girls with a high level of visceral fat mass had markedly higher fasting and glucose-stimulated insulin concentrations than the obese girls with lower visceral fat accumulation. These two subgroups of obese girls had comparable degrees of overall obesity and subcutaneous fat mass. These findings suggest that, even during the early stages of obesity, abdominal visceral obesity, not subcutaneous fat mass, is the most important determinant of glucose metabolism. The striking relationships found in this study between visceral adiposity and insulin secretion in a young population suggest that these findings are not a consequence of long-term obesity, nor are they influenced by confounding life-style factors (e.g., chronic alcohol intake or smoking), but they are actually expressed very early in the natural course of obesity.
The relationship between visceral fat and glucose metabolism may be explained by the unique feature of the visceral fat mass. This fat depot, which is mainly composed of omental and mesenteric fat, is resistant to insulin (12, 29, 33) and is highly sensitive to lipolytic hormones (4). The high lipolytic activity of the visceral adipocytes increases the FFA flux draining into the portal circulation.
In the liver, the increased plasma FFA levels could lead to a decreased hepatic extraction of insulin, thereby increasing peripheral insulin concentrations. Also, high peripheral FFA levels, through an increased rate of lipid oxidation, could decrease glucose oxidation and utilization by the Randle cycle (27). Consistent with this hypothesis, increased FFA levels were found during the euglycemic clamp in the obese adolescent girls, probably because of a reduced antilipolytic effect of insulin. Moreover, lipid oxidation rates were increased during insulin infusion, accounting for the failure of glucose oxidation to rise in the obese girls. In addition to disturbances in FFA metabolism, it is possible that other factors not yet identified play a role in the association between visceral obesity and insulin resistance. In the nonobese adolescent girls, visceral fat mass did not correlate with insulin sensitivity or insulin secretion. In this group, other factors such as the puberty-induced increase in growth hormone may be more important.
Childhood obesity is currently a growing problem in the United States (11, 16) . The results of this study show that increased visceral fat is associated with marked metabolic derangements, even in young subjects. These children, with marked insulin resistance and hyperinsulinemia, also exhibited hypertriglyceridemia and increased blood pressure compared with controls (Table 1) . Thus they already present many of the abnormalities described by Reaven under the term of syndrome X (28). Several prospective population studies have found that the presence of hyperinsulinemia is closely related to the development of cardiovascular disease (13, 18, 35) . Although statistical association does not necessarily imply causality, it does raise a strong argument for the potential role of insulin resistance and hyperinsulinemia in the pathogenesis of atherosclerosis. Adolescents with abdominal obesity, especially those with a high visceral fat content, should be targeted for weight reduction and health surveillance. They are likely, as are obese adults, to be at increased risk for disease states such as coronary artery disease, type II diabetes, and hypertension, which are associated with serious morbidity and mortality.
